BioNexus Gene Lab Receivables 2019-2024 | BGLC
BioNexus Gene Lab Annual Receivables (Millions of US $) |
|
---|---|
2023 | $1 |
2022 | $3 |
2021 | $3 |
2020 | $4 |
2019 | $0 |
2018 | $0 |
BioNexus Gene Lab Quarterly Receivables (Millions of US $) |
|
---|---|
2024-06-30 | $1 |
2024-03-31 | $1 |
2023-12-31 | $1 |
2023-09-30 | $1 |
2023-06-30 | $2 |
2023-03-31 | $3 |
2022-12-31 | $3 |
2022-09-30 | $3 |
2022-06-30 | $3 |
2022-03-31 | $3 |
2021-12-31 | $3 |
2021-09-30 | $4 |
2021-06-30 | $4 |
2021-03-31 | $4 |
2020-12-31 | $4 |
2020-09-30 | $0 |
2020-06-30 | $0 |
2020-03-31 | $0 |
2019-12-31 | $0 |
2019-09-30 | $0 |
2019-06-30 | $0 |
2019-03-31 | $0 |
2018-12-31 | $0 |
2018-09-30 | |
2018-06-30 | |
2018-03-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.008B | $0.010B |
BioNexus Gene Lab Corp. is an emerging company in the business of selling chemical raw materials principally in the Southeast Asia region and the development of biopsy tests for early diagnosis and personalized health management. BioNexus Gene Lab Corp. is based in KUALA LUMPUR, Malaysia. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $125.093B | 15.25 |
Cencora (COR) | United States | $45.021B | 17.20 |
ICON (ICLR) | Ireland | $24.951B | 22.42 |
DiDi Global (DIDIY) | China | $18.956B | 0.00 |
Avantor (AVTR) | United States | $18.396B | 27.90 |
Natera (NTRA) | United States | $15.720B | 0.00 |
Revvity (RVTY) | United States | $15.367B | 26.91 |
Viatris (VTRS) | United States | $14.203B | 4.33 |
CochLear (CHEOY) | Australia | $12.751B | 0.00 |
Solventum (SOLV) | United States | $12.458B | 0.00 |
Medpace Holdings (MEDP) | United States | $11.201B | 33.99 |
Charles River Laboratories (CRL) | United States | $10.641B | 20.11 |
Sonic Healthcare (SKHHY) | Australia | $8.811B | 0.00 |
Doximity (DOCS) | United States | $7.438B | 47.13 |
Bausch + Lomb (BLCO) | Canada | $7.041B | 30.30 |
HealthEquity (HQY) | United States | $6.771B | 36.75 |
PACS (PACS) | United States | $6.218B | 0.00 |
Organon (OGN) | United States | $5.142B | 5.23 |
Life Times (LTH) | United States | $4.879B | 40.78 |
Sotera Health (SHC) | United States | $4.741B | 23.91 |
Surgery Partners (SGRY) | United States | $4.088B | 45.30 |
Concentras Parent (CON) | United States | $2.955B | 0.00 |
GoodRx Holdings (GDRX) | United States | $2.789B | 105.00 |
BrightSpring Health Services (BTSG) | United States | $2.550B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.438B | 0.00 |
Progyny (PGNY) | United States | $2.206B | 38.79 |
Alignment Healthcare (ALHC) | United States | $2.177B | 0.00 |
Premier (PINC) | United States | $2.052B | 9.23 |
Ryman Healthcare (RYHTY) | New Zealand | $1.921B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $1.778B | 8.93 |
Agilon Health (AGL) | United States | $1.642B | 0.00 |
Teladoc Health (TDOC) | United States | $1.556B | 0.00 |
CareDx (CDNA) | United States | $1.543B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.183B | 0.00 | |
GeneDx Holdings (WGS) | United States | $1.044B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.933B | 24.43 |
Pediatrix Medical (MD) | United States | $0.933B | 10.15 |
Embecta (EMBC) | United States | $0.895B | 5.97 |
InnovAge Holding (INNV) | United States | $0.812B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.551B | 0.00 |
Sharecare (SHCR) | United States | $0.527B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.499B | 0.00 |
Enhabit (EHAB) | United States | $0.410B | 35.48 |
Sonida Senior Living (SNDA) | United States | $0.370B | 0.00 |
DocGo (DCGO) | United States | $0.361B | 13.58 |
Sera Prognostics (SERA) | United States | $0.261B | 0.00 |
Biodesix (BDSX) | United States | $0.253B | 0.00 |
LifeMD (LFMD) | United States | $0.226B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.194B | 0.00 |
ModivCare (MODV) | United States | $0.192B | 6.11 |
Beauty Health (SKIN) | United States | $0.187B | 0.00 |
MultiPlan (MPLN) | United States | $0.152B | 0.00 |
Nutex Health (NUTX) | United States | $0.126B | 0.00 |
Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.083B | 0.00 |
So-Young (SY) | China | $0.081B | 19.72 |
Singular Genomics Systems (OMIC) | United States | $0.042B | 0.00 |
NeueHealth (NEUE) | United States | $0.042B | 1.66 |
Co-Diagnostics (CODX) | United States | $0.041B | 0.00 |
OncoCyte (OCX) | United States | $0.039B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.030B | 0.00 |
Pheton Holdings (PTHL) | China | $0.028B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
Oncology Institute (TOI) | United States | $0.023B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.021B | 0.00 |
TRxADE HEALTH (MEDS) | United States | $0.010B | 0.00 |
XWELL (XWEL) | United States | $0.010B | 0.00 |
KindlyMD (KDLY) | $0.008B | 0.00 | |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
ISpecimen (ISPC) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |